Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annual Review of Medicine

• Publication date

  2013-01-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1146/annurev-med-092611-084441PMID 23327526PMCID PMC3625402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Therapeutic Antibody Targeting Bace1 Inhibits Amyloid-beta Production in Vivo

  2013cited by this paper
• Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model

  2013cited by this paper
• Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice

  2013cited by this paper
• ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

  2012cited by this paper
• Effects of membrane lipids on the activity and processivity of purified γ-secretase.

  2012cited by this paper
• The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

  2012cited by this paper
• The ethics of early evidence--preparing for a possible breakthrough in Alzheimer's disease.

  2012cited by this paper
• Propagation of tau pathology in a model of early Alzheimer's disease.

  2012cited by this paper
• P2‐145: Development of an induced pluripotent stem cell (iPSC) Alzheimer's disease model using PSEN1 mutant fibroblasts

  2012cited by this paper
• Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study

  2012cited by this paper
• High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease

  2012cited by this paper
• Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers

  2012cited by this paper
• Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial

  2012cited by this paper
• APOE ε4 Status and Traumatic Brain Injury on the Gridiron or the Battlefield

  2012cited by this paper
• Trans-Synaptic Spread of Tau Pathology In Vivo

  2012cited by this paper
• Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain

  2012cited by this paper
• P3‐380: Effects of extended‐release memantine (28 mg, once daily) on language and communication abilities in a randomized trial of patients with moderate‐to‐severe Alzheimer's disease

  2012cited by this paper
• A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

  2012cited by this paper
• Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.

  2012cited by this paper
• Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis

  2012cited by this paper
• Retromer Binds the FANSHY Sorting Motif in SorLA to Regulate Amyloid Precursor Protein Sorting and Processing

  2012cited by this paper
• iPSCs to the rescue in Alzheimer's research.

  2012cited by this paper
• Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

  2012cited by this paper
• Dementia from Alzheimer disease and mixed pathologies in the oldest old.

  2012cited by this paper
• Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

  2012cited by this paper
• Genome-Wide Analysis of a Wnt1-Regulated Transcriptional Network Implicates Neurodegenerative Pathways

  2011cited by this paper
• Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance

  2011cited by this paper
• Perspective: Prevention is better than cure

  2011cited by this paper
• Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons.

  2011cited by this paper
• Revision of the criteria for Alzheimer's disease: A symposium

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• S3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain

  2011cited by this paper
• Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging

  2011cited by this paper
• Chronic traumatic encephalopathy in an Iraqi war veteran with posttraumatic stress disorder who committed suicide.

  2011cited by this paper
• Physical Exercise Protects Against Alzheimer's Disease in 3xTg-AD Mice

  2011cited by this paper
• Six-Month Walking Program Changes Cognitive and ADL Performance in Patients With Alzheimer

  2011cited by this paper
• Testing the Right Target and Right Drug at the Right Stage

  2011cited by this paper
• Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.

  2011cited by this paper
• Review: Contact sport‐related chronic traumatic encephalopathy in the elderly: clinical expression and structural substrates

  2011cited by this paper
• Dissociation between the processivity and total activity of γ-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations.

  2011cited by this paper
• Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.

  2011cited by this paper
• Mild cognitive impairment, dementia, and their subtypes in oldest old women.

  2011cited by this paper
• A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo

  2011cited by this paper
• Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging

  2010cited by this paper
• Traumatic brain injury: football, warfare, and long-term effects.

  2010influential reference
• Validation of consensus panel diagnosis in dementia.

  2010cited by this paper
• A PHASE 2 MULTIPLE ASCENDING DOSE TRIAL OF BAPINEUZUMAB IN MILD TO MODERATE ALZHEIMER DISEASE

  2010cited by this paper
• Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people.

  2010cited by this paper
• 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.

  2010cited by this paper
• Revising the definition of Alzheimer's disease: a new lexicon.

  2010cited by this paper
• Diabetes-Associated SorCS1 Regulates Alzheimer's Amyloid-β Metabolism: Evidence for Involvement of SorL1 and the Retromer Complex

  2010cited by this paper
• Chronic traumatic encephalopathy in a professional American wrestler

  2010cited by this paper
• Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid‐β oligomers

  2010cited by this paper
• Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's Disease.

  2010cited by this paper
• Testing the amyloid hypothesis of Alzheimer's disease in vivo.

  2010cited by this paper
• Gamma-secretase activating protein, a therapeutic target for Alzheimer's disease

  2010cited by this paper
• The genetics of Alzheimer disease: back to the future.

  2010influential reference
• Traumatic brain injury--football, warfare, and long-term effects.

  2010cited by this paper
• Transmission and spreading of tauopathy in transgenic mouse brain

  2009cited by this paper
• Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.

  2009cited by this paper
• A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

  2009cited by this paper
• Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery.

  2009cited by this paper
• Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.

  2009cited by this paper
• 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.

  2009cited by this paper
• The role of apolipoprotein E in Alzheimer's disease.

  2009cited by this paper
• APOE ε4 and bapineuzumab

  2009cited by this paper
• apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.

  2008cited by this paper
• Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.

  2008cited by this paper
• Natural human antibodies to amyloid beta peptide.

  2008cited by this paper
• Exercise Program for Nursing Home Residents with Alzheimer's Disease: A 1‐Year Randomized, Controlled Trial

  2007cited by this paper
• The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

  2007cited by this paper
• Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees

  2007cited by this paper
• Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease.

  2007cited by this paper
• Loss‐of‐function presenilin mutations in Alzheimer disease

  2007cited by this paper
• Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

  2007cited by this paper
• Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus

  2006cited by this paper
• Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

  2006cited by this paper
• Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.

  2006influential reference
• Chronic Traumatic Encephalopathy in a National Football League Player.

  2006cited by this paper
• Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

  2006cited by this paper
• Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.

  2005cited by this paper
• Chronic traumatic encephalopathy in a National Football League player.

  2005cited by this paper
• Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.

  2004cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Gleevec inhibits β-amyloid production but not Notch cleavage

  2003cited by this paper
• Gleevec inhibits beta-amyloid production but not Notch cleavage.

  2003cited by this paper
• Antihistamine Agent Dimebon As a Novel Neuroprotector and a Cognition Enhancer

  2001cited by this paper
• Activity-dependent regulation of neuronal plasticity and self repair.

  2000cited by this paper
• Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.

  2000cited by this paper
• Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner.

  1999cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper
• The apolipoprotein E ε4 allele is not a significant risk factor for frontotemporal dementia

  1998cited by this paper
• The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.

  1998cited by this paper
• Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing.

  1997influential reference
• Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease

  1995cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.

  1993cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

  1980cited by this paper
• Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

  1980cited by this paper

• A Systemic Pathological Network Model and Combinatorial Intervention Strategies for Alzheimer's Disease

  2025cites this paper
• Syringaldehyde Ameliorates Cognitive Dysfunction in APP/PS1 Mice by Stabilizing the NLRP3 Pathway

  2025cites this paper
• Heterogeneous treatment effects of BCG vaccine on Alzheimer's disease risk

  2025cites this paper
• Repurposing oncology drugs for Alzheimer’s: multi-omic convergence targeting cell-cycle, proteostasis, immunometabolism, and senescence

  2025cites this paper
• Evolving Insights into Prickle2 in Neurodevelopment and Neurological Disorders

  2025cites this paper
• Therapeutic effects of a novel synthetic α-secretase

  2024cites this paper
• Multi-target directed ligands inspired natural products as an effective approach for the treatment of complex chronic health disorders.

  2024cites this paper
• Differential Effects of Endocannabinoids on Amyloid-Beta Aggregation and Toxicity

  2023cites this paper
• ApoE Alzheimer’s Disease Aβ-amyloid plaque morphology varies according to APOE isotype

  2023cites this paper
• Exposure to Low Levels of Radiofrequency Electromagnetic Fields Emitted from Cell-phones as a Promising Treatment of Alzheimer’s Disease: A Scoping Review Study

  2023cites this paper
• Alzheimer’s Disease A<i>β</i>-Amyloid Plaque Morphology Varies According to <i>APOE</i> Isotype

  2023cites this paper
• POPULATION EPIDEMIOLOGICAL STUDY OF DEMENTIA IN THE CITY OF LONDRINA - PARANÁ - BRAZIL

  2022cites this paper
• Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections.

  2022cites this paper
• Comparison of Cerebral Cortex Transcriptome Profiles in Ischemic Stroke and Alzheimer’s Disease Models

  2022cites this paper
• Mechanistic considerations and biomarkers level in nickel-induced neurodegenerative diseases: An updated systematic review

  2022cites this paper
• Neuroprotective effects of donepezil against Aβ25-35-induced neurotoxicity

  2022cites this paper
• New Multifunctional Agents for Potential Alzheimer’s Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones

  2022cites this paper
• Coexistence of Multiple Sclerosis and Alzheimer Disease Pathology: A Case Series

  2021cites this paper
• STC1 ameliorates cognitive impairment and neuroinflammation of Alzheimer's disease mice via inhibition of ERK1/2 pathway.

  2021cites this paper
• Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation

  2021cites this paper
• A method for the expression of fibroblast growth factor 14 and assessment of its neuroprotective effect in an Alzheimer’s disease model

  2021cites this paper
• Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation

  2021cites this paper
• Regulation of cell distancing in peri-plaque glial nets by Plexin-B1 affects glial activation and amyloid compaction in Alzheimer’s disease

  2021cites this paper
• Alzheimer’s disease as a systems network disorder: chronic stress/dyshomeostasis, innate immunity, and genetics

  2020cites this paper
• Ginsenoside Rg1 ameliorates the cognitive deficits in D-galactose and AlCl3-induced aging mice by restoring FGF2-Akt and BDNF-TrkB signaling axis to inhibit apoptosis

  2020cites this paper
• Gold Nanoparticles Mediate Improved Detection of β-amyloid Aggregates by Fluorescence

  2020cites this paper
• Alzheimer-related genes show accelerated evolution

  2020cites this paper
• New Multifunctional Agents Based on Conjugates of 4-Amino-2,3-polymethylenequinoline and Butylated Hydroxytoluene for Alzheimer’s Disease Treatment

  2020cites this paper
• Liver Growth Factor “LGF” as a Therapeutic Agent for Alzheimer’s Disease

  2020cites this paper
• A Novel Nanosystem Realizing Curcumin Delivery Based on Fe3O4@Carbon Dots Nanocomposite for Alzheimer’s Disease Therapy

  2020cites this paper
• GSAP Regulates Amyloid Beta Production through Modulation of Amyloid Precursor Protein Trafficking

  2020cites this paper
• Associations between vascular risk factors and subsequent Alzheimer’s disease in older adults

  2020cites this paper
• The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale – Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment

  2019cites this paper
• Coexistence of Multiple Sclerosis and Alzheimer's disease: A review.

  2019cites this paper
• Associations Between Positron Emission Tomography Amyloid Pathology and Diffusion Tensor Imaging Brain Connectivity in Pre-Clinical Alzheimer's Disease

  2019cites this paper
• Integrative Approach to Sporadic Alzheimer ’ s Disease : Deficiency of driver Tyrobp / Dap 12 in cerebral A β amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing A β burden

  2019cites this paper
• Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden

  2018cites this paper
• The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease

  2018cites this paper
• Biological evaluation and energetic analyses of novel GSK‐3β inhibitors

  2018cites this paper
• Diagnòstic i monitorització de la malaltia d'Alzheimer mitjançant tècniques de ressonància magnètica in vivo en el model 3xTg-AD :

  2017cites this paper
• Effect of retinoid X receptor-α nuclear export inhibition on apoptosis of neurons in vivo and in vitro.

  2017cites this paper
• The effect of dietary supplementation on brain-derived neurotrophic factor and cognitive functioning in Alzheimer's dementia

  2017cites this paper
• Comparison of the glycopattern alterations of mitochondrial proteins in cerebral cortex between rat Alzheimer’s disease and the cerebral ischemia model

  2017cites this paper
• Therapeutic Links between Anti-Cancer Drugs and Alzheimer’s Disease: A Review

  2017cites this paper
• Viral Vector Gene Delivery to the Brain for Treating Neurogenetic Diseases

  2017cites this paper
• Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease

  2017cites this paper
• Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment

  2017cites this paper
• Phage display and kinetic selection of antibodies that specifically inhibit amyloid self-replication

  2017cites this paper
• Intermittent hypoxia training: Powerful, non-invasive cerebroprotection against ethanol withdrawal excitotoxicity.

  2017cites this paper
• Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration

  2017cites this paper
• Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer’s Disease

  2017cites this paper
• Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer's disease: A meta-analysis

  2017cites this paper
• Drug and Gene Delivery to the Central Nervous System for Neuroprotection

  2017cites this paper
• The emerging role of anticancer-drugs-Bexarotene in a clinical trial of Alzheimer’s dementia

  2017cites this paper
• Vincamine Alleviates Amyloid-β 25–35 Peptides-induced Cytotoxicity in PC12 Cells

  2017cites this paper
• Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations

  2017cites this paper
• Comparing the Effects of Multisensory Stimulation and Individualized Music Sessions on Elderly People with Severe Dementia: A Randomized Controlled Trial

  2016cites this paper
• Hybrids: a new paradigm to treat Alzheimer’s disease

  2016cites this paper
• Modulating Role of TTR in Aβ Toxicity, from Health to Disease

  2016influential citation
• Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative

  2016cites this paper
• Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease

  2016influential citation
• Intra and Interindividual Variation Modeling: Bayesian Mixed-Effects Nonstationary Latent Differential Equation Model

  2016cites this paper
• Epidemiology: Then and Now.

  2016cites this paper
• Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer's brain molecular pathology

  2015cites this paper
• Luteinizing hormone as a key player in the cognitive decline of Alzheimer's disease.

  2015cites this paper
• Amyloid and tau pathology of familial Alzheimer’s disease APP/PS1 mouse model in a senescence phenotype background (SAMP8)

  2015cites this paper
• Role of P2X7 and P2Y2 receptors on α-secretase-dependent APP processing: Control of amyloid plaques formation “in vivo” by P2X7 receptor

  2015cites this paper
• The crystal structure of DR6 in complex with the amyloid precursor protein provides insight into death receptor activation

  2015cites this paper
• Effect of graphene oxide on the conformational transitions of amyloid beta peptide: A molecular dynamics simulation study.

  2015cites this paper
• Study of early stages of amyloid Aβ13-23 formation using molecular dynamics simulation in implicit environments

  2015cites this paper
• Compromised MAPK signaling in human diseases: an update

  2015cites this paper
• Inhibition of c‐Jun N‐terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice

  2015cites this paper
• Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer’s Disease: What are the Roadblocks and How Can They Be Overcome?

  2015cites this paper
• Utility of autoantibodies as biomarkers for diagnosis and staging of neurodegenerative diseases.

  2015cites this paper
• Biomarkers in the diagnosis and management of Alzheimer's disease.

  2015cites this paper
• [Nutritional approaches to modulate oxidative stress that induce Alzheimer's disease. Nutritional approaches to prevent Alzheimer's disease].

  2015cites this paper
• Nutrición que previene el estrés oxidativo causante del Alzheimer. Prevención del Alzheimer

  2015cites this paper
• Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.

  2015cites this paper
• La transconformation protéique, nouveau paradigme en neurologie

  2015cites this paper
• [Spreading of protein misfolding: A new paradigm in neurology].

  2015cites this paper
• Effects of viewing a preferred nature image and hearing preferred music on engagement, agitation, and mental status in persons with dementia

  2015cites this paper
• Efecto del resveratrol en modelos murinos de envejecimiento y enfermedad de Alzheimer

  2014cites this paper
• FKBP14 in Notch Signalling and Drosophila Development

  2014cites this paper
• Regenerating the brain: Stem cell differentiation and cholinergic dysfunction in Alzheimer disease

  2014influential citation
• Design, synthesis and biological evaluation of novel 6H-benzo[c]chromen-6-one, and 7,8,9,10-tetrahydro-benzo[c]chromen-6-one derivatives as potential cholinesterase inhibitors.

  2014cites this paper
• 5-HT6 receptor antagonists as treatment for age-related cognitive decline

  2014cites this paper
• Environmental exposures and the risk for Alzheimer disease: can we identify the smoking guns?

  2014cites this paper
• Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides.

  2014cites this paper
• Tanshinone IIA promotes non-amyloidogenic processing of amyloid precursor protein in platelets via estrogen receptor signaling to phosphatidylinositol 3-kinase/Akt.

  2014cites this paper
• Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.

  2014cites this paper
• [3H]‐L685,458 Binding Sites are Abundant in Multiple Peripheral Organs in Rats: Implications for Safety Assessment of Putative γ‐Secretase Targeting Drugs

  2014cites this paper
• Alzheimer’s Disease: New Data Highlight Nonneuronal Cell Types and the Necessity for Presymptomatic Prevention Strategies

  2014cites this paper
• Acetylcholinesterase Modulates Presenilin-1 Levels and γ-Secretase Activity

  2014cites this paper
• Synchronizing an aging brain: can entraining circadian clocks by food slow Alzheimer’s disease?

  2014cites this paper
• Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease

  2014cites this paper
• Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells

  2014cites this paper
• Critical periods in adult neurogenesis and possible clinical utilization of new neurons

  2014cites this paper
• Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse

  2014cites this paper
• Acat1 knockdown gene therapy decreases amyloid-β in a mouse model of Alzheimer's disease.

  2013cites this paper
• The Women's Healthy Ageing Project: Fertile ground for investigation of healthy participants ‘at risk’ for dementia

  2013cites this paper